
Higher cancer rates linked to WWII radioactive waste in Midwestern creek
A Missouri creek has allegedly led to a higher risk of cancer in neighboring residents.
Coldwater Creek, a Missouri River tributary north of St. Louis, has been a known radioactive waste site since the 1980s.
Researchers have now confirmed that exposure to the creek, which is said to be polluted with nuclear waste from the development of the first atomic bomb, has led to an increased incidence of cancer for people who were children in the area between the 1940s and 1960s.
MAN'S DEADLY BRAIN CANCER TUMOR DISAPPEARS AFTER EXPERIMENTAL DRUG TRIAL
A study from the Harvard T.H. Chan School of Public Health, which was published in JAMA Network, analyzed the data of 4,209 participants who lived near Coldwater Creek.
The data was originally gathered for a previous study on childhood radiation exposure.
Participants who lived in the Greater St. Louis area between 1958 and 1972 shared their cancer diagnoses, which allowed researchers to calculate risk based on their proximity to the creek.
The researchers found an elevated risk of cancer in a long-term follow-up, with those who lived closest to the creek reporting a higher incidence of most cancers.
"The waste from these entities could have huge impacts on people's health, even at lower levels of exposure."
In total, 24% of study participants reported having cancer. Of those, 30% lived less than one kilometer away from the creek, 28% lived between one and five kilometers away, 25% lived between five and 20 kilometers away, and 24% lived more than 20 kilometers away.
Corresponding author Marc Weisskopf, professor of environmental epidemiology and physiology at Harvard T.H. Chan School of Public Health, commented on these findings in a press release.
CHILDREN EXPOSED TO HIGHER FLUORIDE LEVELS FOUND TO HAVE LOWER IQS, STUDY REVEALS
"Our research indicates that the communities around North St. Louis appear to have had excess cancer from exposure to the contaminated Coldwater Creek," he said.
"These findings may have broader implications — as countries think about increasing nuclear power and developing more nuclear weapons, the waste from these entities could have huge impacts on people's health, even at these lower levels of exposure."
This study accompanies Congress' passing of an expanded version of the Radiation Exposure Compensation Act (RECA), as part of President Trump's Big Beautiful Bill.
The act will allow Americans, including Coldwater Creek residents, to receive compensation for medical bills associated with radiation exposure, the researchers noted.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Local agencies have become increasingly concerned about cancer prevalence in the area, prompting the push for further research beyond the U.S. government's acknowledgment of the pollution four decades ago.
The contamination originally occurred due to the Manhattan Project and Mallinckrodt Chemical Works, which processed and refined uranium in St. Louis, according to the study.
The radioactive material was moved out of the major U.S. city and into the more rural area near Coldwater Creek, where it was stored in uncovered drums on the ground and exposed to the elements, allowing contaminants to leach into the nearby creek.
The researchers noted that communities downstream from Coldwater Creek had potentially been exposed to the ionizing radiation during recreational activities, such as playing in the creek, and residential activities, like breathing in dust suspended from the soil when gardening.
For more Health articles, visit www.foxnews.com/health
The study did have some limitations, the researchers acknowledged, including its small sample size and reliance on self-reported cancer outcomes.
The potential carcinogenic impact of creek exposure warrants further research to confirm the findings, the team concluded.
Co-author Michael Leung, PhD, post-doctoral research fellow at Harvard's Department of Environmental Health, reflected on the findings in an interview with Fox News Digital.
"Our study found that children in the 1940s to 1960s who lived near Coldwater Creek, which was contaminated by radioactive waste from the development of the first atomic bomb, had a 44% higher risk of cancer compared to those living further than 20 kilometers away," he confirmed.
CLICK HERE TO GET THE FOX NEWS APP
"Our findings coincide with Congress passing an expanded version of the Radiation Exposure Compensation Act, and gives further credence to the health concerns of St. Louis area-residents about the contaminated creek," Leung went on.
"We hope these findings will support public health measures for affected communities, as well as ongoing efforts to remediate the creek."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
28 minutes ago
- Fox News
China ‘closer than ever' to surpassing American-made AI models
Fox News chief political anchor Bret Baier reports on the global artificial intelligence race on 'Special Report.'

Yahoo
30 minutes ago
- Yahoo
HealthStream: Q2 Earnings Snapshot
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — HealthStream Inc. (HSTM) on Monday reported net income of $5.4 million in its second quarter. On a per-share basis, the Nashville, Tennessee-based company said it had profit of 18 cents. The provider of internet-based educational and training content for health care professionals posted revenue of $74.4 million in the period. HealthStream expects full-year revenue in the range of $297.5 million to $303.5 million. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on HSTM at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
Addus HomeCare (NASDAQ:ADUS) Surprises With Q2 Sales
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q2 CY2025 results exceeding the market's revenue expectations , with sales up 21.8% year on year to $349.4 million. Its non-GAAP profit of $1.49 per share was 1.8% above analysts' consensus estimates. Is now the time to buy Addus HomeCare? Find out in our full research report. Addus HomeCare (ADUS) Q2 CY2025 Highlights: Revenue: $349.4 million vs analyst estimates of $346.5 million (21.8% year-on-year growth, 0.8% beat) Adjusted EPS: $1.49 vs analyst estimates of $1.46 (1.8% beat) Adjusted EBITDA: $43.93 million vs analyst estimates of $43.08 million (12.6% margin, 2% beat) Operating Margin: 9.4%, in line with the same quarter last year Sales Volumes rose 32.7% year on year (-2.8% in the same quarter last year) Market Capitalization: $1.91 billion Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, 'Addus delivered another strong financial and operating performance for the second quarter of 2025, as we continued to execute our strategy with consistent and favorable results. Notably, our net service revenue for the second quarter of 2025 was up 21.8% year-over-year, and adjusted EBITDA increased 24.5% over the same period last year. These results reflect solid organic growth and include the additional revenue from the personal care operations of Gentiva, which we acquired on December 2, 2024. We continue to see robust demand for our services, reflecting the growing recognition of the value and cost-effectiveness of home-based care. With our proven operating model across the continuum of care and expanding scale in key markets, Addus is well positioned to meet this demand and continue to capitalize on additional growth opportunities. Company Overview Serving approximately 66,000 clients across 22 states with a focus on "dual eligible" Medicare and Medicaid beneficiaries, Addus HomeCare (NASDAQ:ADUS) provides in-home personal care, hospice, and home health services to elderly, chronically ill, and disabled individuals. Revenue Growth A company's long-term sales performance can indicate its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Thankfully, Addus HomeCare's 11.6% annualized revenue growth over the last five years was decent. Its growth was slightly above the average healthcare company and shows its offerings resonate with customers. Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Addus HomeCare's annualized revenue growth of 12.9% over the last two years is above its five-year trend, suggesting its demand recently accelerated. We can better understand the company's revenue dynamics by analyzing its number of average billable patients, which reached 50,404 in the latest quarter. Over the last two years, Addus HomeCare's average billable patients averaged 12% year-on-year growth. Because this number is in line with its revenue growth, we can see the company kept its prices fairly consistent. This quarter, Addus HomeCare reported robust year-on-year revenue growth of 21.8%, and its $349.4 million of revenue topped Wall Street estimates by 0.8%. Looking ahead, sell-side analysts expect revenue to grow 12.9% over the next 12 months, similar to its two-year rate. This projection is healthy and suggests the market is baking in success for its products and services. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Operating Margin Operating margin is an important measure of profitability as it shows the portion of revenue left after accounting for all core expenses – everything from the cost of goods sold to advertising and wages. It's also useful for comparing profitability across companies with different levels of debt and tax rates because it excludes interest and taxes. Addus HomeCare was profitable over the last five years but held back by its large cost base. Its average operating margin of 8.1% was weak for a healthcare business. On the plus side, Addus HomeCare's operating margin rose by 2.6 percentage points over the last five years, as its sales growth gave it operating leverage. Zooming in on its more recent performance, we can see the company's trajectory is intact as its margin has also increased by 1.3 percentage points on a two-year basis. This quarter, Addus HomeCare generated an operating margin profit margin of 9.4%, in line with the same quarter last year. This indicates the company's overall cost structure has been relatively stable. Earnings Per Share Revenue trends explain a company's historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions. Addus HomeCare's spectacular 13.4% annual EPS growth over the last five years aligns with its revenue performance. This tells us its incremental sales were profitable. In Q2, Addus HomeCare reported adjusted EPS at $1.49, up from $1.35 in the same quarter last year. This print beat analysts' estimates by 1.8%. Over the next 12 months, Wall Street expects Addus HomeCare's full-year EPS of $5.59 to grow 14.7%. Key Takeaways from Addus HomeCare's Q2 Results It was good to see Addus HomeCare narrowly top analysts' revenue and EPS expectations this quarter. On the other hand, its sales volume slightly missed. Overall, this was still a decent quarter. The stock traded up 1.5% to $108.75 immediately after reporting. So should you invest in Addus HomeCare right now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it's free. Sign in to access your portfolio